4894.T

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
4894.TCuorips Inc.	$5740.00	-1.37%	$47.4B	—
197A.TTAUNS Laboratories, Inc.	$515.00	+0.39%	$54.8B	—
3151.TVital KSK Holdings, Inc.	$1612.00	+0.19%	$77.5B	—
368A.TKitazato Corporation	$1438.00	+0.56%	$57.5B	—
4593.THealios K.K.	$289.00	+0.70%	$39.0B	—
4820.TEM Systems Co., Ltd.	$585.00	-0.68%	$40.5B	—
4886.TASKA Pharmaceutical Holdings Co.,Ltd.	$2110.00	+1.34%	$59.9B	—

Source: Financial Modeling Prep · peers by sector/industry

Cuorips Inc.

Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.

cuorips.co.jp

Employees: 51
IPO / List date: Jun 27, 2023
HQ: JP

Held by traders on TradeandTell

No one on the platform currently holds 4894.T.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 4894.T as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 4894.T yet.